show help

Oliveira M

Author page

This page provides a summary of the entries in Polbase associated with this author.

The publication history graph presents the number of publications in Polbase by this author over time.

The polymerase chart indicates which polymerases this author has published on.

Polbase automatically discovers many polymerase papers as they are published. Some relevant papers are not included because the algorithm is designed to reduce background. Please contribute to polbase by adding your missing DNA polymerase papers.

Help icons:

The show help symbol in the upper-right corner of the page links to this help text. The question mark icon is used everywhere to indicate that help is available.

Missing references?

Publications:

Title Authors Year Journal
Antiviral activity and resistance profile of phosphazid--a novel prodrug of AZT. Oliveira M Nucleosides & nucleotides
The preferential selection of K65R in HIV-1 subtype C is attenuated by nucleotide polymorphisms at thymidine analogue mutation sites. Oliveira M 2013 The Journal of antimicrobial chemotherapy
The Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and their Interactions with the M184I Mutation in Defining Patterns of Resistance to the Non-Nucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine. Oliveira M 2013 Antimicrobial agents and chemotherapy
Basis for the Early and Preferential Selection of the E138K Substitution in HIV-1 Reverse Transcriptase with Etravirine. Oliveira M 2013 Antimicrobial agents and chemotherapy
Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral load. Oliveira M 2012 Antimicrobial agents and chemotherapy
A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1. Oliveira M 2011 PloS one
Characterization of the E138K resistance mutation in HIV-1 reverse transcriptase conferring susceptibility to etravirine in B and non-B HIV-1 subtypes. Oliveira M 2011 Antimicrobial agents and chemotherapy
Compensation by the E138K mutation in HIV-1 reverse transcriptase for deficits in viral replication capacity and enzyme processivity associated with the M184I/V mutations. Oliveira M 2011 Journal of virology
Transmission dynamics of the M184V drug resistance mutation in primary HIV infection. Oliveira M 2011 The Journal of antimicrobial chemotherapy
Comparative biochemical analysis of recombinant reverse transcriptase enzymes of HIV-1 subtype B and subtype C. Oliveira M 2010 Retrovirology
Differential impact of the HIV-1 non-nucleoside reverse transcriptase inhibitor mutations K103N and M230L on viral replication and enzyme function. Oliveira M 2010 The Journal of antimicrobial chemotherapy
Human immunodeficiency virus type 1 recombinant reverse transcriptase enzymes containing the G190A and Y181C resistance mutations remain sensitive to etravirine. Oliveira M 2009 Antimicrobial agents and chemotherapy
Apricitabine does not select additional drug resistance mutations in tissue culture in human immunodeficiency virus type 1 variants containing K65R, M184V, or M184V plus thymidine analogue mutations. Oliveira M 2009 Antimicrobial agents and chemotherapy
Template usage is responsible for the preferential acquisition of the K65R reverse transcriptase mutation in subtype C variants of human immunodeficiency virus type 1. Oliveira M 2009 Journal of virology
Signature nucleotide polymorphisms at positions 64 and 65 in reverse transcriptase favor the selection of the K65R resistance mutation in HIV-1 subtype C. Oliveira M 2009 The Journal of infectious diseases
Near full-length genomic analysis of a novel subtype A1/C recombinant HIV type 1 isolate from Canada. Oliveira M 2008 AIDS research and human retroviruses
Transmission networks of drug resistance acquired in primary/early stage HIV infection. Oliveira M 2008 AIDS (London, England)
Diminished efficiency of HIV-1 reverse transcriptase containing the K65R and M184V drug resistance mutations. Oliveira M 2007 AIDS (London, England)
Variations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine. Oliveira M 2007 Antimicrobial agents and chemotherapy
HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture. Oliveira M 2006 AIDS (London, England)
High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens. Oliveira M 2006 Antimicrobial agents and chemotherapy
Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection. Oliveira M 2004 AIDS (London, England)
Differential maintenance of the M184V substitution in the reverse transcriptase of human immunodeficiency virus type 1 by various nucleoside antiretroviral agents in tissue culture. Oliveira M 2004 Antimicrobial agents and chemotherapy
The M184V substitution in human immunodeficiency virus type 1 reverse transcriptase delays the development of resistance to amprenavir and efavirenz in subtype B and C clinical isolates. Oliveira M 2003 Antimicrobial agents and chemotherapy
Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutation. Oliveira M 2003 Antimicrobial agents and chemotherapy
A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. Oliveira M 2003 AIDS (London, England)
Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT. Oliveira M 2002 Antimicrobial agents and chemotherapy
Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection. Oliveira M 2002 Journal of virology
The M184V mutation in reverse transcriptase can delay reversion of attenuated variants of simian immunodeficiency virus. Oliveira M 2002 Journal of virology
Co-receptor usage and HIV-1 intra-clade C polymorphisms in the protease and reverse transcriptase genes of HIV-1 isolates from Ethiopia and Botswana. Oliveira M 2002 Antiviral therapy
Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance. Oliveira M 2002 Antiviral research
Pressure of zidovudine accelerates the reversion of lamivudine resistance-conferring M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1. Oliveira M 2002 Antimicrobial agents and chemotherapy
Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC. Oliveira M 2000 Antiviral chemistry & chemotherapy
All Authors

Using Polbase tables:

Sorting:

Tables may be sorted by clicking on any of the column titles. A second click reverses the sort order. <Ctrl> + click on the column titles to sort by more than one column (e.g. family then name).

Filtering:

It is also possible to filter the table by typing into the search box above the table. This will instantly hide lines from the table that do not contain your search text.